Nabriva Therapeutics plc (NBRVF)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: May 5, 2025
Nabriva Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2013 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2013 - 2017 |
| Cash & Equivalents | 12.41 | 47.66 | 41.36 | 86.02 | 102 | Upgrade
|
| Short-Term Investments | - | 0.02 | 0.02 | 0.18 | 0.23 | Upgrade
|
| Cash & Short-Term Investments | 12.41 | 47.68 | 41.38 | 86.19 | 102.23 | Upgrade
|
| Cash Growth | -73.96% | 15.23% | -52.00% | -15.68% | 17.67% | Upgrade
|
| Accounts Receivable | 5.95 | 12.21 | 3.79 | 1.53 | 4.26 | Upgrade
|
| Other Receivables | 0.79 | 0.54 | 0.12 | 1.21 | 1.11 | Upgrade
|
| Receivables | 6.74 | 12.75 | 3.91 | 2.74 | 5.37 | Upgrade
|
| Inventory | 9.68 | 14.51 | 5.82 | 0.68 | - | Upgrade
|
| Prepaid Expenses | 2.15 | 5.16 | 5.88 | 1.16 | 1.15 | Upgrade
|
| Restricted Cash | 0.12 | 0.18 | 0.23 | 0.39 | - | Upgrade
|
| Total Current Assets | 31.1 | 80.27 | 57.22 | 91.17 | 108.75 | Upgrade
|
| Property, Plant & Equipment | 0.28 | 0.23 | 0.77 | 2.47 | 1.14 | Upgrade
|
| Other Intangible Assets | 0 | 0.03 | 0.08 | 0.09 | 0.1 | Upgrade
|
| Other Long-Term Assets | 0.38 | 0.38 | 0.37 | 0.38 | 0.43 | Upgrade
|
| Total Assets | 31.77 | 80.91 | 58.44 | 94.11 | 110.42 | Upgrade
|
| Accounts Payable | 5.43 | 4.37 | 2.89 | 4.67 | 3.3 | Upgrade
|
| Accrued Expenses | 7.15 | 9.45 | 5.89 | 8.63 | 12.86 | Upgrade
|
| Current Portion of Long-Term Debt | 4.83 | 3.77 | 2.04 | - | - | Upgrade
|
| Current Unearned Revenue | - | 0.37 | 0.75 | - | - | Upgrade
|
| Other Current Liabilities | 10.19 | 4.38 | 6.96 | 3.34 | 1.65 | Upgrade
|
| Total Current Liabilities | 27.61 | 22.34 | 18.52 | 16.64 | 17.81 | Upgrade
|
| Long-Term Debt | 0.39 | 4.27 | 5.69 | 34.5 | 23.72 | Upgrade
|
| Other Long-Term Liabilities | 0.48 | 0.95 | 1.09 | 1.7 | 0.26 | Upgrade
|
| Total Liabilities | 28.47 | 27.56 | 25.3 | 52.84 | 41.79 | Upgrade
|
| Common Stock | 0.03 | 0.02 | 0.21 | 0.1 | 0.67 | Upgrade
|
| Additional Paid-In Capital | 656.1 | 648.98 | 579.12 | 517.89 | 461.91 | Upgrade
|
| Retained Earnings | -652.86 | -595.68 | -546.23 | -476.74 | -393.98 | Upgrade
|
| Comprehensive Income & Other | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
| Shareholders' Equity | 3.29 | 53.35 | 33.14 | 41.27 | 68.63 | Upgrade
|
| Total Liabilities & Equity | 31.77 | 80.91 | 58.44 | 94.11 | 110.42 | Upgrade
|
| Total Debt | 5.22 | 8.03 | 7.73 | 34.5 | 23.72 | Upgrade
|
| Net Cash (Debt) | 7.19 | 39.65 | 33.65 | 51.69 | 78.51 | Upgrade
|
| Net Cash Growth | -81.86% | 17.82% | -34.91% | -34.16% | -9.39% | Upgrade
|
| Net Cash Per Share | 2.68 | 22.86 | 65.49 | 174.17 | 386.40 | Upgrade
|
| Filing Date Shares Outstanding | 3.2 | 2.42 | 1 | 0.38 | 0.28 | Upgrade
|
| Total Common Shares Outstanding | 3.2 | 2.27 | 0.84 | 0.38 | 0.27 | Upgrade
|
| Working Capital | 3.5 | 57.93 | 38.69 | 74.53 | 90.95 | Upgrade
|
| Book Value Per Share | 1.03 | 23.52 | 39.30 | 109.14 | 256.01 | Upgrade
|
| Tangible Book Value | 3.29 | 53.32 | 33.06 | 41.18 | 68.53 | Upgrade
|
| Tangible Book Value Per Share | 1.03 | 23.50 | 39.20 | 108.90 | 255.64 | Upgrade
|
| Machinery | 4.8 | 4.59 | 4.67 | 4.6 | 4.6 | Upgrade
|
Updated Oct 19, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.